ACOR Acorda Therapeutics Inc

Acorda Therapeutics Inc is a biopharmaceutical company. It is engaged in the identification, development & commercialization of novel therapies for the treatment of neurological disorders.

$0.52  -0.04 (-7.13%)
As of 06/24/2022 16:00:01 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/10/2006
Outstanding shares:  13,285,636
Average volume:  5,387,096
Market cap:   $5,347,577
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   -0.07
PB ratio:   0.05
PS ratio:   0.04
Return on equity:   -74.50%
Net income %:   -77.42%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy